• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病无症状高尿酸血症的治疗:宿敌中的新靶点——综述

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.

作者信息

Ramirez Maria Erika G, Bargman Joanne M

机构信息

University Health Network, 200 Elizabeth Street 8N-840, Toronto M5G 2C4, Canada.

出版信息

J Adv Res. 2017 Sep;8(5):551-554. doi: 10.1016/j.jare.2017.04.006. Epub 2017 May 2.

DOI:10.1016/j.jare.2017.04.006
PMID:28748121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5512147/
Abstract

Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function.

摘要

无症状性高尿酸血症的患病率正在上升。越来越多的文献表明,尿酸对血管健康和肾脏组织学完整性具有有害影响。本文综述的几项试验表明,降低血清尿酸水平与减缓慢性肾脏病患者的肾脏恶化速度相关。鉴于在常规治疗手段中几乎没有什么可以减缓肾脏恶化速度,对于肾功能恶化的高尿酸血症患者,可大力考虑给予能减少尿酸生成的药物或改变生活方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071a/5512147/64d19cc6862c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071a/5512147/64d19cc6862c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071a/5512147/64d19cc6862c/fx1.jpg

相似文献

1
Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.慢性肾脏病无症状高尿酸血症的治疗:宿敌中的新靶点——综述
J Adv Res. 2017 Sep;8(5):551-554. doi: 10.1016/j.jare.2017.04.006. Epub 2017 May 2.
2
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.通过降低血清尿酸水平的能力,使用别嘌醇来减缓肾脏疾病的进展。
Am J Kidney Dis. 2006 Jan;47(1):51-9. doi: 10.1053/j.ajkd.2005.10.006.
3
A role for uric acid in the progression of renal disease.尿酸在肾脏疾病进展中的作用。
J Am Soc Nephrol. 2002 Dec;13(12):2888-97. doi: 10.1097/01.asn.0000034910.58454.fd.
4
Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.白首乌可增强别嘌醇的降血尿酸作用。
J Ethnopharmacol. 2015 Mar 13;162:362-8. doi: 10.1016/j.jep.2015.01.012. Epub 2015 Jan 21.
5
Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.降尿酸药物治疗 3-4 期慢性肾脏病无症状高尿酸血症:肾功能的争议作用。
PLoS One. 2019 Jun 17;14(6):e0218510. doi: 10.1371/journal.pone.0218510. eCollection 2019.
6
Hyperuricemia induces endothelial dysfunction.高尿酸血症会导致内皮功能障碍。
Kidney Int. 2005 May;67(5):1739-42. doi: 10.1111/j.1523-1755.2005.00273.x.
7
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia.使用别嘌醇降低尿酸可改善无症状高尿酸血症患者的胰岛素抵抗和全身炎症。
J Investig Med. 2015 Dec;63(8):924-9. doi: 10.1097/JIM.0000000000000242.
8
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.别嘌醇治疗高尿酸血症对肾功能正常患者血压、肌酐清除率及蛋白尿的影响。
Int Urol Nephrol. 2007;39(4):1227-33. doi: 10.1007/s11255-007-9253-3. Epub 2007 Aug 15.
9
The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.血清尿酸降低对慢性肾脏病高尿酸血症患者肾功能和血压的影响。
Clin Exp Nephrol. 2018 Dec;22(6):1300-1308. doi: 10.1007/s10157-018-1580-4. Epub 2018 Apr 26.
10
Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease.比较别嘌醇和非布司他在高尿酸血症慢性肾脏病患者中的护肾作用。
Int Urol Nephrol. 2019 Mar;51(3):467-473. doi: 10.1007/s11255-018-2051-2. Epub 2019 Jan 2.

引用本文的文献

1
Knowledge, attitude, and practice toward hyperuricemia among healthcare workers in Shandong, China.中国山东医护工作者对高尿酸血症的认知、态度和实践。
PeerJ. 2024 Oct 1;12:e17926. doi: 10.7717/peerj.17926. eCollection 2024.
2
Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study.尿酸转运蛋白1可成为慢性肾脏病和糖尿病肾病的治疗靶点分子:一项回顾性纵向研究
Biomedicines. 2023 Feb 15;11(2):567. doi: 10.3390/biomedicines11020567.
3
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population.

本文引用的文献

1
Vascular Function and Uric Acid-Lowering in Stage 3 CKD.3期慢性肾脏病患者的血管功能与尿酸降低
J Am Soc Nephrol. 2017 Mar;28(3):943-952. doi: 10.1681/ASN.2016050521. Epub 2016 Sep 12.
2
Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy.慢性肾脏病的管理:血清尿酸与肾病发展之间的关系
Adv Ther. 2015 Dec;32(12):1177-91. doi: 10.1007/s12325-015-0272-7. Epub 2015 Dec 9.
3
The effect of angiotensin II receptor blockers on hyperuricemia.血管紧张素 II 受体阻滞剂对高尿酸血症的影响。
生活方式相关的危险因素对健康中青年人群慢性肾脏病的发生和进展的影响。
Nutrients. 2022 Sep 14;14(18):3787. doi: 10.3390/nu14183787.
4
Hyperuricemia, the heart, and the kidneys - to treat or not to treat?高尿酸血症、心脏和肾脏-治疗还是不治疗?
Ren Fail. 2020 Nov;42(1):978-986. doi: 10.1080/0886022X.2020.1822185.
5
Allopurinol Effects on Residual Renal Function in End-Stage Renal Disease Patients Undergoing Peritoneal Dialysis: Randomized Controlled Trial.别嘌醇对接受腹膜透析的终末期肾病患者残余肾功能的影响:随机对照试验
J Res Pharm Pract. 2019 Dec 27;8(4):189-195. doi: 10.4103/jrpp.JRPP_18_72. eCollection 2019 Oct-Dec.
6
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy.与别嘌醇相关的严重皮肤不良反应:意大利南部自发报告系统分析
Drugs Real World Outcomes. 2020 Mar;7(1):41-51. doi: 10.1007/s40801-019-00174-7.
7
Approximate Mortality Risks between Hyperuricemia and Diabetes in the United States.美国高尿酸血症与糖尿病之间的近似死亡风险
J Clin Med. 2019 Dec 3;8(12):2127. doi: 10.3390/jcm8122127.
8
Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.治疗伴有肾损伤的无症状高尿酸血症:一个有争议的问题。
Int Urol Nephrol. 2019 Dec;51(12):2227-2233. doi: 10.1007/s11255-019-02256-5. Epub 2019 Aug 28.
9
Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey.医生对慢性肾脏病患者无症状高尿酸血症的认知:一项问卷调查
Kidney Res Clin Pract. 2019 Sep 30;38(3):373-381. doi: 10.23876/j.krcp.19.007.
10
Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis.无症状高尿酸血症与进展至血液透析的慢性肾脏病患者的心血管死亡率。
Int Urol Nephrol. 2019 Jun;51(6):1013-1018. doi: 10.1007/s11255-019-02154-w. Epub 2019 Apr 24.
Ther Adv Chronic Dis. 2015 Nov;6(6):339-46. doi: 10.1177/2040622315596119.
4
Regulation of uric acid metabolism and excretion.尿酸代谢与排泄的调节。
Int J Cardiol. 2016 Jun 15;213:8-14. doi: 10.1016/j.ijcard.2015.08.109. Epub 2015 Aug 14.
5
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.非布司他在慢性肾脏病伴无症状高尿酸血症患者中降低肾小球滤过率下降速度的疗效:一项 6 个月、双盲、随机、安慰剂对照试验。
Am J Kidney Dis. 2015 Dec;66(6):945-50. doi: 10.1053/j.ajkd.2015.05.017. Epub 2015 Jul 30.
6
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.降低尿酸治疗改善慢性肾脏病患者肾脏结局:系统评价与荟萃分析
BMC Nephrol. 2015 Apr 19;16:58. doi: 10.1186/s12882-015-0047-z.
7
Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.尿酸通过血管胰岛素抵抗导致一氧化氮合成受损,从而引起内皮功能障碍。
FASEB J. 2014 Jul;28(7):3197-204. doi: 10.1096/fj.13-247148. Epub 2014 Mar 20.
8
Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.尿酸——心肾代谢综合征“配方”中的关键成分。
Cardiorenal Med. 2013 Oct;3(3):208-220. doi: 10.1159/000355405.
9
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.降尿酸治疗对肾脏结局的影响:一项系统评价和荟萃分析。
Nephrol Dial Transplant. 2014 Feb;29(2):406-13. doi: 10.1093/ndt/gft378. Epub 2013 Sep 15.
10
Allopurinol for prevention of progression of kidney disease with hyperuricemia.别嘌醇用于预防高尿酸血症伴发的肾脏疾病进展。
Indian J Nephrol. 2013 Jul;23(4):280-6. doi: 10.4103/0971-4065.114499.